Spots Global Cancer Trial Database for carcinoma, squamous
Every month we try and update this database with for carcinoma, squamous cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma | NCT05323253 | Recurrent Squam... | DaRT seeds | 18 Years - | Alpha Tau Medical LTD. | |
| Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer | NCT00591149 | Head and Neck C... Carcinoma, Squa... | Oxaliplatin Docetaxel Cetuximab | 18 Years - | University of Kansas Medical Center | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | NCT04534127 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC | NCT05047094 | Head and Neck S... Skin Cancer Metastatic Head... | Diffusing Alpha... Pembrolizumab | 18 Years - | Alpha Tau Medical LTD. | |
| Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | NCT04540588 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer | NCT01445405 | Carcinoma, Squa... Head and Neck C... Oral Cancer Laryngeal Cance... Pharyngeal Canc... | Bortezomib (Vel... Cetuximab Cisplatin Radiation Thera... | 18 Years - 90 Years | National Institutes of Health Clinical Center (CC) | |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | NCT03886181 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Device: Radiati... | 18 Years - | Alpha Tau Medical LTD. | |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma | NCT05964101 | Neoplasms Carcinoma, Squa... Antineoplastic ... | Nivolumab Injec... | 18 Years - 75 Years | The First Affiliated Hospital of Guangzhou Medical University | |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | NCT03886181 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Device: Radiati... | 18 Years - | Alpha Tau Medical LTD. | |
| A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment | NCT01497041 | Carcinoma, Non-... Carcinoma, Squa... Carcinoma, Larg... | Docetaxel Oxaliplatin | 18 Years - | Korean South West Oncology Group | |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) | NCT03737734 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma | NCT03015883 | Squamous Cell C... | Diffusing Alpha... | 18 Years - | Alpha Tau Medical LTD. | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer | NCT00591149 | Head and Neck C... Carcinoma, Squa... | Oxaliplatin Docetaxel Cetuximab | 18 Years - | University of Kansas Medical Center | |
| ctDNA and MRI Parameters in Head and Neck Cancer | NCT06215612 | Head and Neck N... Carcinoma, Squa... | Blood draw, MRI | 19 Years - 100 Years | Medical University of Vienna |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
